Theseus begins phase II Apomate trial:
This article was originally published in Clinica
Executive Summary
North American Scientific's (NAS) subsidiary, Theseus Imaging, has begun a US, phase II clinical study of its nuclear imaging agent, Apomate, for assessing a patient's response to chemotherapy (see Clinica No 952, p 16). The trial will include patients with breast cancer, lung cancer and lymphoma, says NAS of Chatsworth, California.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.